J = 14.3, H-5); 4.13 (1H, s, H-1); 7.33-7.35 (3H, m, Ph, H-3,4,5); 7.46-7.48 (2H, d, J = 7.2, Ph, H-2,6);
7.67-7.79 (4H, m, PiN). 13C NMR spectrum, δ, ppm: 26.9 (CH3); 30.4 (CH3); 35.2 (C(4)); 35.9 (C(3)); 50.0 (C(5));
54.0 (C(1)); 76.1 (C(6)); 122.5 and 123.2 (PiN, C(3,6) and Ph, C(2,6)); 129.0 (Ph, C(3,5)); 130.2 (PiN, C(1,2)); 131.4
(Ph, C(4)); 134.1 (PiN, C(4,5)); 151.3 (Ph, C(1)); 164.2 (PiN, C=O); 202.4 (C(2)). Found, %: C 67.94; H 4.71;
N 13.04. C22H20N4O3. Calculated, %: C 68.03; H 5.19; N 14.42.
Addition of 3-Amino-2-methylquinazolin-4(3H)-one to Cyclopenten-1-ylazobenzene (1a) (5 mmol).
The oily residue (692 mg) was dissolved in a minimum amount of ether and the precipitate formed was filtered
off (336 mg (42%) of the quinazolinone). The filtrate was evaporated on a rotary evaporator to give 2-phenyl-
2,4,5,6-tetrahydrocyclopenta-1,2,3-triazole 4a (344 mg, 37%) as white crystals with mp 62°C (lit. mp 62-64°C
[4, 5]). The 1H and 13C NMR spectra for the compound obtained agreed with data in [4, 5].
Addition of 3-Amino-2-methylquinazolin-4(3H)-one to 1-Nitro-4-(cyclopenten-1-ylazo)benzene
(1b) (0.6 mmol). Several fractions of the filtrate with change in intensity of the solution color were collected
when filtering through a layer of silica gel. The latter colorless fraction contained only 2-methylquinazolin-
4(3H)-one (53 mg). The remaining fractions were combined and the solvent distilled off in vacuo. The 1H NMR
spectrum of the mixture obtained showed a characteristic triplet for the aziridine proton at 3.93 ppm. The oily
residue (183 mg) was chromatographed of a silica gel column (20 g) using petroleum ether–methylene chloride
(4:1), gradually increasing its polarity to 1: 1 to give the starting azo compound 1b (20 mg, 15%) and
2-(4-nitrophenyl)-2,4,5,6-tetrahydrocyclopenta-1,2,3-triazole 4b (120 mg, 87%) as yellowish crystals with
mp 227-229°C (decomp.) and Rf 0.63 (ether). 1H NMR spectrum, δ, ppm (J, Hz): 2.58 (2H, q, J = 7.6, H-5); 2.87
13
(4H, t, J = 7.6, H-4,6); 8.09 (2H, d, J = 9.3, Ar, H-2,6); 8.28 (2H, d, J = 9.3, Ar, H-3,5). C NMR spectrum,
δ, ppm: 22.1 (C(4,6)); 28.7 (C(5)); 117.9 (Ar, C(2,6)); 125.2 (Ar, C(3,5)); 144.6 and 145.3 (Ar, C(1,4)), 159.0 (C(3a,6a)).
Found, %: C 57.61; H 4.48; N 23.39. C11H10N4O2. Calculated, %: C 57.39; H 4.35; N 24.35.
Later fractions contained 2-methylquinazolin-4(3H)-one (27 mg) (overall yield 80 mg (82%)).
Addition of 3-Amino-2-methylquinazolin-4(3H)-one to Cyclohexen-1-ylazobenzene (1c) (5 mmol)
to give the starting azo compound 1c (200 mg, 22%), 2-phenyl-4,5,6,7-tetrahydro-2H-benzotriazole 4c (12 mg,
1
1%) as white crystals with mp 70°C. H NMR spectrum, δ, ppm (J, Hz): 1.85-1.90 (4H, m, H-5,6); 2.78-2.82
13
(4H, m, H-4,7); 7.25 (1H, t, Ph, H-4); 7.42 (2H, t, Ph,, H-3,5); 7.96 (2H, d, Ph, H-2,6). C NMR spectrum, δ,
ppm: 21.9 (C5,6); 23.1 (C4,7); 118.3 (Ph, C2,6); 126.5 (Ph, C4); 129.2 (Ph, C3,5); 140.1 (Ph, C1); 145.7 (C3a,7a)]
together with 1.209 g of a mixture of the aziridine 3c and 2-methylquinazolin-4(3H)-one. The last fraction was
triturated with a small amount of a low polarity mixture of cold petroleum ether and ether. The crystals formed
were filtered off, the filtrate was evaporated on a rotary evaporator, and the residue was recrystallized from
methanol. The yield of 2-methyl-3-(1-phenylazo-7-azabicyclo[4.1.0]hept-7-yl)quinazolin-4(3H)-one (3c) was
653 mg (37%, 47% based on recovered starting azo compound) as yellow needles with mp 98-101°C. 1H NMR
spectrum, δ, ppm (J, Hz): 1.50-1.76 (4H, m, H-3,4); 1.97-2.21 (2H, m, H-5); 2.38 (3H, s, CH3); 2.62-2.70 (1H,
m, H-2); 2.94-3.01 (1H, m, H-2); 3.20 broad signal and 3.98 (d, J = 4.1) overall 1H, H-6; 7.26-7.46 (6H, m, Ph
and MeQN, H-6); 7.57-7.72 (2H, m, MeQN, H-7,8); 8.24 (1H, d, J = 8, MeQN, H-5). 13C NMR spectrum,
δ, ppm: 19.8, 20.5, 23.2, 23.6 (C(2,3,4,5)); 22.6 (MeQN, Me); 53.0 (C(6)); 76.6 (C(1)); 121.4 (C(4a)); 122.1 (Ph,
C(2,6)); 126.0, 126.1, 126.4 (MeQN, C(5,6,8)); 128.8 (Ph, C(3,5)); 131.2 (Ph, C(4)); 133.5 (MeQN, C(7)); 145.9 (C(8a));
151.4 (Ph, C(1)); 154.0 (MeQN, C(2)); 160.1 (MeQN, C(4)). Found, %: C 70.24; H 5.96; N 19.91. C21H21N5O.
Calculated, %: C 70.20; H 5.85; N 19.50.
The yield of the 2-methylquinazolin-4(3H)-one was 365 mg (45%).
Addition of 3-Amino-2-methylquinazolin-4(3H)-one to 1-Nitro-4-(cyclohexen-1-ylazo)benzene (1d)
(2 mmol) to give the starting azo compound 1d (54 mg, 12%) and 2-methyl-3-(1-(4-nitrophenyl)azo-7-
azabicyclo[4.1.0]hept-7-yl)quinazolin-4(3H)-one 3d (364 mg, 45%, 51% based on recovered starting azo
1
compound) as yellow crystals with mp 180.4-181.1°C. H NMR spectrum, δ, ppm (J, Hz): 1.47-1.82 (4H, m,
H-3,4); 2.04-2.24 (2H, m, H-5); 2.35 (3H, br. s, MeQN, CH3); 2.62-2.74 (1H, m, H-2); 3.00 (1H, ddd, J = 14.6,
J = 8, J = 6, H-2); 3.39 br. s and 4.15 br. s (1H, H-6); 7.40-7.48 (3H, m, Ar, H-2,6 and MeQN, H-6); 7.60 (1H,
901